Helene Herje • 1984 • Molde • 7 roles • 10 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
T TANNLEGE HELENE HERJE AS	Managing Director/CEO	4,410,632	2,366,600	100 % directly
T TANNLEGENE I MYRABAKKEN AS	Managing Director/CEO	11,180,343	1,201,714	50 % indirectly
M MYRABAKKEN 5 AS	Managing Director/CEO	1,685,593	199,875	50 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
T TANNLEGE HELENE HERJE AS	Chairman	4,410,632	2,366,600	100 % directly
T TANNLEGESENTERET AS	Board Member	565,035	2,208,818	50 % indirectly
T TANNLEGENE I MYRABAKKEN AS	Chairman	11,180,343	1,201,714	50 % indirectly
M MYRABAKKEN 5 AS	Chairman	1,685,593	199,875	50 % indirectly

Last update: Dec 2, 2024

Related industries1

Health and social
/ Dental health

Direct relationships3

Shares owned by Helene Herje

Name	Share class	Total operating income	Total equity	Share
T TANNLEGE HELENE HERJE AS	Ordinære aksjer	4,410,632	2,366,600	100 % directly
T TANNLEGESENTERET AS		565,035	2,208,818	50 % indirectly
T TANNLEGENE I MYRABAKKEN AS		11,180,343	1,201,714	50 % indirectly
M MYRABAKKEN 5 AS		1,685,593	199,875	50 % indirectly
S SALMON EVOLUTION ASA	NO0010892094	29,376,000	2,164,477,000	< 0.01 % directly
S SALMAR ASA	NO0010310956	836,826,000	10,049,628,000	< 0.01 % directly
N NORDIC SEMICONDUCTOR ASA	NO0003055501	508,026,000	554,883,000	< 0.01 % directly
E EQUINOR ASA	NO0010096985	72,543,000,000	41,090,000,000	< 0.01 % directly
N NYKODE THERAPEUTICS ASA	NO0010714785	13,362,000	174,832,000	< 0.01 % directly
A AKER BP ASA	NO0010345853	13,670,000,000	12,371,000,000	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025